PatientZero
New

One Patient. Every Perspective. Data Decides.

Drop your DICOM scans, lab reports, doctor's notes, research papers — everything. Both patient and clinician use the same workspace with the same tools. AI synthesizes all voices. Labs don't lie. Imaging doesn't lie. Data is the tiebreaker.

HIPAA-aligned consent and authorization required at intake. Your data is encrypted at rest and in transit. AI analysis is supplemental — not diagnostic.

Total Patients

1

Active (7d)

1

With Complaints

1

Patients (1)

B

BERN-821207-APSE

male
1982-12-07Since Mar 2026Last seen Mar 15, 2026
COMPREHENSIVE PATIENT CASE REPORT Confidential Medical Document — For Provider Use 1. PATIENT DEMOGRAPHICS Name: John Bernard DOB: 12/07/1982 | Age: 43 | Sex: Male Phone: (720) 429-6466 Email: brad.b.bernard@gmail.com Current Location: Greenville, SC (previously San Antonio, TX; Asheville, NC; Atlanta, GA) PCP: Dr. Iskra Magick Myers Current Surgeon: Dr. John Palmer, Palmer Distinctive Dentistry, Greenville, SC (IAOMT Mastership) 2. CHIEF COMPLAINT Progressive bilateral maxillary bone disease of 18+ months duration. Chronic pain, bone loss, non-healing surgical sites, 4 molar extractions, multiple failed antibiotic courses, and systemic symptoms including fatigue, nausea, sleep disruption, bilateral foot edema with erythromelalgia pattern, neuropathy, and local anesthesia resistance. Self-ordered labs on March 2, 2026 revealed normocalcemic primary hyperparathyroidism and positive ANA with nucleolar pattern (systemic sclerosis association). 3. RELEVANT MEDICAL HISTORY 3a. General Medical History • Sobriety: 15+ years sober. No alcohol or recreational drugs. Critical: opioids contraindicated per patient preference and history. • ADHD: Diagnosed, treated with dextroamphetamine sulfate (daily). • Chronic depersonalization: Since age 16. Described as living with "one foot in each world." • Neuropathy: Bilateral feet — spots that do not respond normally to touch. Large tendons tighten intermittently causing gait difficulty. Patient uses tuning fork vibration therapy for symptomatic relief. • Erythromelalgia pattern: Feet turn red and swell in heat (hot shower steam, prolonged standing in warm environments). Consistent with small vessel vasomotor dysfunction. • Previous vascular crisis: Present at time of La Cantera Dental procedures (Feb 2025). Nature not fully documented. • Ancestry: Italian, Ashkenazi, Cherokee. Relevant for autoimmune predisposition (Ashkenazi — elevated scleroderma risk). 3b. Dental/Surgical History (Chronological) DATE PROVIDER LOCATION PROCEDURE / FINDINGS Feb 21, 2025 La Cantera Dental San Antonio, TX Full-mouth SRP + 8 composite fillings (#3, #10, #14, #15, #29, #30, #31 +1) + RCT redo on #10 with Core-X build-up + gingival irrigation + desensitizer x8. Single session. No clinical notes or imaging documenting caries. May 2025 Endodontist San Antonio, TX Root canal on #3. May 26, 2025 Zam Dental / Dr. Zamora San Antonio, TX Crown #3. Crown oversized. Adjacent teeth #2 and #4 ground down. Crown cemented by student. Zamora pulled on crown, stated "I'm done," left room. $3,500 cash — two insurances refused. Jun 2025 Dr. Robert Naples, OFS Round Rock, TX Extracted #3. Found necrotic bone. Placed cadaver bone graft. Graft never integrated. MRI 9 months later: persistent marrow edema at graft site. Jul-Sep 2025 Dr. Kevin Chang / Transcend Round Rock, TX Multiple visits. CBCT obtained. Vertical root fracture #14 not identified for 5 months. Aug-Sep 2025 Multiple biological dentists San Antonio, TX Laser therapy, ozone injections, IV ozone therapy. Infection persisted. Sep 2025 Olmos Dental San Antonio, TX Ozone injection. Diagnosed TMJ and nervous system overload. Sep 2025 Vaughn Endo TX 2-hour evaluation. Stated could attempt RCT #14 but cannot guarantee no extraction. Stated #15 needs crown (contradicting Olmos finding). Oct 2025 Dr. Nunnally, Nunnally Freeman Owens Marble Falls, TX Extracted #15. Intraoperative findings: "mush, dead blood vessels, tissue your body wanted to push out." No biopsy obtained. No culture obtained. No bone graft placed (per patient request). #15 site has NOT healed at 5 months post-extraction. Nov 2025 Capital ENT & Sinus Center Lakeway, TX ENT evaluation for sinus burning and bitter drainage. Endoscopy performed. Oroantral communication suspected. Nov 2025 Governor-appointed Periodontist TX Stated: "You do NOT have periodontal disease." Fall 2025 Multiple providers (6+) NC Anders Dental: refused to see patient. Chicory Family: "I can't help you." Asheville MaxFax: delayed 30 days for being 20 min late. Southern Dental: diagnosed trigeminal neuralgia. Embark Dental: agreed to extract, reversed, discharged. Fall 2025 Atrium Health / Mission Imaging NC Nuclear bone scan (Tc-99m): Active bilateral maxillary uptake. Focal throat uptake (possible parathyroid adenoma). Radiologist read: TMD, nothing abnormal. Dec 2025 Prisma Greenville, Pelham MC, Bon Secours ERs SC 3 ERs in 48 hours. Pelham labs: Monocytes 10.5%, Basophils 1.2%, PLT 397, MPV 7.0 L. Patient requested CRP/ESR — refused. All discharged without treatment. Dec 2025 Emory University Hospital ER Atlanta, GA Morphine administered without informed consent to 15+ year sober patient. Clindamycin prescribed despite prior neurotoxicity concern. OMFS available in-house, not consulted. 24 hrs vomiting, missed antibiotic doses. Jan 2026 Mission Imaging NC Nuclear bone scan obtained (referenced above). Feb 2026 Angel Medical Center ER Franklin, NC WBC 12.0 — active infection. Discharged without antibiotics. Feb 2026 Concierge Internist SC Multiple visits. Did not order PTH or ANA. Feb 2026 CBCT (self-obtained) NC/SC Patient reviewed own imaging. Irregular bone density patterns anterior maxilla consistent with necrotic/ischemic bone changes. Heterogeneous marrow pattern bilaterally. ~Feb 2026 Periodontal maintenance cleaning SC Post-cleaning, patient swished Listerine. Thick white biofilm/bone debris expelled. Fistula at #15 opened. #14 began to throb. Alkaline carbonation sensation at #14 — consistent with calcium carbonate effervescence from actively dissolving bone. Mar 2, 2026 PATIENT SELF-ORDERED Quest Diagnostics Self-ordered: PTH Intact, Calcium, Vitamin D 25-OH, ANA Cascade with reflex, Autoimmune/Inflammation Marker Panel, Osteoporosis Panel, RF, CCP, ESR, CRP. First provider to order PTH or ANA in 18 months. Mar 5, 2026 Dr. Palmer Greenville, SC Left side osseous NICO debridement #14-#15. #14 extracted. Sinus lift. PRF plug placed. Right side NOT completed — local anesthesia ineffective, patient in pain. Surgeon terminated. Hard mass (involucrum) above #14 site not addressed. #13 palatal swelling not addressed. Tooth scraping collected by patient into DNA Connections PCR kit, refrigerated. 4. ACTIVE SYMPTOMS — CURRENT 4a. Oral/Maxillofacial • Left maxilla: Post-surgical. Oozing (pinkish, not active bleeding). Stitches at #14 extraction and posterior to #15. Deep pressure previously at #14 now RESOLVED post-surgery. Palatal swelling at #13 NOT resolved — tender, firm, on opposite side of surgical incision. • Right maxilla (#2): Active. Twitching/vibrating sensation under gums. Internal bubbling identical to pre-extraction #14. Interpreted as active bone dissolution or gas-producing anaerobic bacterial activity. • Hard mass above #14 site: Palpable, solid, root-shaped indentation. Tooth is extracted (in patient's possession). Mass is consistent with involucrum — reactive bone formed around chronic osteomyelitis. • #15 socket: Empty, soft, mush-like. Non-healing at 5 months. Consistent with avascular bone bed. • Lower jaw (#29, #30, #31): Palpable bone lumps under gums at all three La Cantera filling sites. • Alkaline taste: Intermittent. Consistent with calcium phosphate leaching from dissolving bone. • Sinus: Left sinus communication addressed by Palmer today (sinus lift/plug). Right sinus — bitter drainage, burning, previously documented oroantral communication suspected. 4b. Systemic • Bilateral foot edema: Feet swell and turn red in heat (hot shower, prolonged standing). Pattern consistent with erythromelalgia / small vessel vasomotor dysfunction. Spots on feet that do not respond normally to touch (small fiber neuropathy). Large foot tendons tighten intermittently. • Nausea: Intermittent. Correlates with sinus drainage into stomach and with elevated calcium (hypercalcemia symptom). • Fatigue: Chronic. Consistent with both hyperparathyroidism and autoimmune disease. • Sleep disruption: Chronic. Medication interaction (magnesium malate + gabapentin) exacerbates — magnesium competes at same voltage-gated calcium channels gabapentin modulates. • Vasodilation episodes: "Niacin flush" sensation without taking niacin. Consistent with histamine release from active bone remodeling / osteoclast activity. • Facial swelling: Fluctuates. Recently noted to be less swollen by provider (possible inflammation reduction on doxycycline). Interpreted by patient as bone/tissue edema from vascular compromise. • Local anesthesia resistance: Documented failure during surgery March 5, 2026. Mechanism: elevated serum calcium stabilizes sodium channels, antagonizing lidocaine/articaine. 5. CURRENT MEDICATIONS 5a. Prescription Medications MEDICATION DOSE FREQUENCY NOTES Dextroamphetamine sulfate Per Rx Daily ADHD. Held morning of surgery, resume Day 2. Long-term (5+ years). Gabapentin Per Rx Daily Neuropathic pain. INTERACTION: Magnesium malate competes at same voltage-gated calcium channels. Must separate by 2+ hours. INTERACTION: Elevated calcium from hyperparathyroidism affects channel function. Long-term gabapentin associated with decreased BMD — accelerant in context of active PTH-driven bone resorption. Clonidine Per Rx Daily Blood pressure / sleep. Clindamycin 500 mg 3x/day (TID) Current course: Day 9 of current cycle. ONE DAY SUPPLY REMAINING as of March 5. CRITICAL: Does not cover gram-negatives. Previous Augmentin courses may have selected for resistant gram-negative organisms. No culture-directed antibiotic therapy has ever been attempted. Zofran (ondansetron) Per Rx PRN nausea As needed. Toradol (ketorolac) Per Rx PRN pain Days 1-5 Post-surgical pain management. 5b. Current Supplement Protocol SUPPLEMENT DOSE TIMING PURPOSE / NOTES Vitamin D3 10,000 IU Daily Despite 10K daily, 25-OH level only 37 ng/mL (barely adequate). Body is burning through D3 for calcium homeostasis. Target: 60-80 ng/mL. Vitamin K2 (D3/K2 drops) Per label Daily Activates osteocalcin (drives calcium INTO bone) and matrix GLA protein (keeps calcium OUT of arteries). Despite supplementation, bones still dissolving — PTH overpowering K2 signal. Bone Restore Elite 4 caps Daily (lunch) Calcium, magnesium, minerals for bone support. MUST separate from Clindamycin by 3-4 hours — calcium blocks antibiotic absorption. Post-op: restart Day 2-3. Magnesium Malate 3 tabs Daily INTERACTION: Competes with gabapentin at voltage-gated calcium channels. Separate by 2+ hours. INTERACTION: Shifts Ca:Mg ratio — can trigger sweating, restless legs, excitatory rebound in context of hyperparathyroidism. PerfectAmino Per label Morning (empty stomach) Essential amino acids for tissue repair. No bleeding or interaction risk. Colostrum Per label Morning (empty stomach) Immune support, gut repair. Sodium Ascorbate (Vitamin C) Per label 2x/day Antioxidant, collagen synthesis, immune support. Arginine Citrulline Per label Afternoon (Day 4+) Nitric oxide production, blood flow to bone. POST-OP: Hold Days 1-3 (vasodilator, increases bleeding risk). Elderberry Per label Dinner Immune support. Cell Salts Per label 2x/day Mineral support. DentaMedica Per label Daily Dental-specific nutritional support. Gut Spore + Gut Connection Per label Daily Probiotic / gut integrity. Relevant given multiple antibiotic courses. Lymph Tonic Per label Afternoon Lymphatic drainage support. Buffalo Bone Tea Per label Day 3+ Bone-building minerals, traditional preparation. Burbur-Pinella Drops 2x/day tapering Detoxification support. Manuka Honey Topical + oral Daily (Day 4+ on sites) Antimicrobial wound application on surgical ridges. Also taken orally. L-Theanine Per label Bedtime Calming, sleep support. Passion Flower Tea Tea Bedtime Sleep support. Celtic Sea Salt Per taste In water, food Mineral replenishment, electrolyte balance. Bone Broth Cup Daily Collagen, minerals, gut repair. 5c. Supplements Currently HELD (Post-Surgical) SUPPLEMENT RESTART REASON FOR HOLD CuraMed Curcumin Week 3 Blood thinning properties, bleeding risk post-surgery. Vitamin E 400 IU Week 2 Blood thinning. NAC Week 3 (half dose) Resume low and build up. Niacin Week 2 Vasodilator — increases bleeding risk. CBD Softgels Day 4 Mild blood thinning. Nattokinase / Serrapeptase Week 3 Fibrinolytic — significant bleeding risk. G.I. Detox Binder Week 2 Must be 2 hours from all other supplements/meds. 5d. Topical / Therapeutic Modalities • Red/Pink light therapy wand: Applied externally to cheeks over surgical areas. 2-3 minutes per side. Starting Day 5+. • Tuning forks: Used on feet for neuropathy symptom relief. Gentle near jaw from Day 6+. • Magnesium lotion: Topical, nightly. • XyliSwish: Xylitol-based oral rinse. NOT until Day 7+. No swishing — gentle rinse only. • Baking soda rinse: Passive soak (not swishing) starting Day 2. Gravity drain. • Ancient Magnetic Clay + bath salts: Detox baths, weekly from Day 6+. • Methylene blue: Used diagnostically by patient to identify cracks/pathology on extracted teeth. NOT for oral application on surgical sites. • DMSO: In emergency kit. Not currently in active use. 6. FAILED ANTIBIOTIC COURSES The following antibiotics have been administered over 18 months without culture-directed targeting. No bone culture or pathogen identification has ever been performed until the patient's self-collected DNA Connections PCR sample on March 5, 2026. ANTIBIOTIC COVERAGE OUTCOME Augmentin (multiple courses) Gram+, gram-, anaerobes GI destruction (nausea, vomiting). May have selected for resistant organisms. Temporary symptom relief only. Clindamycin (multiple courses) Gram+, anaerobes. NO gram-negative coverage. Current course Day 9. Does NOT cover gram-negatives that Augmentin may have selected for. Gap in coverage. Doxycycline Broad spectrum + bone penetration Some stabilization noted. Bone penetration advantageous. Interacts with calcium supplements (separate by 3-4 hrs). Others (unspecified) Various 6+ total courses. All empiric. None culture-directed. All failed to resolve underlying bone infection. CRITICAL: No provider has ever obtained a bone culture or tissue culture for sensitivity testing. Treatment has been empiric for 18 months. 7. LABORATORY DATA 7a. Calcium Trend Over Time DATE CALCIUM REF RANGE NOTES Aug 2, 2025 9.1 8.6-10.3 Baseline. ~Sep 2025 9.8 8.6-10.3 Rising. ~Oct 2025 9.0 8.6-10.3 Transient dip. ~Nov 2025 10.1 8.6-10.3 At upper limit. ~Dec 2025 10.0 8.6-10.3 Sustained high. Mar 2, 2026 9.9 8.6-10.3 High-normal. With PTH 58, this = inappropriately non-suppressed PTH. Normocalcemic primary hyperparathyroidism. Trend: Calcium persistently at or near upper reference limit despite 10,000 IU Vitamin D + K2 + Bone Restore supplementation. No provider ordered PTH until patient self-ordered. 7b. March 2, 2026 — Self-Ordered Panel (Quest Diagnostics) TEST VALUE RANGE INTERPRETATION PTH, Intact 58 pg/mL 16-77 Upper half of range. Inappropriately elevated for calcium of 9.9. Should be suppressing. Indicates autonomous parathyroid function. Calcium 9.9 mg/dL 8.6-10.3 High-normal. Paired with PTH 58 = normocalcemic primary hyperparathyroidism. Vitamin D, 25-OH 37 ng/mL 30-100 Barely adequate despite 10,000 IU/day. Body consuming D for calcium homeostasis. Rules out secondary hyperparathyroidism from D deficiency — this is primary. ANA Screen, IFA POSITIVE NEGATIVE Antinuclear antibodies detected. ANA Titer 1:40 H <1:40 Neg Low titer. However, nucleolar pattern is clinically significant regardless of titer. ANA Pattern Nuclear, Nucleolar N/A AC-8,9,10 Nucleolar. Associated with: systemic sclerosis (scleroderma), scleroderma/polymyositis overlap, Sjogren's syndrome. Scleroderma causes small vessel fibrosis/constriction — explains ischemic bone disease, non-healing surgical sites, erythromelalgia, local anesthesia resistance. Rheumatoid Factor <10 IU/mL <14 Negative. RA ruled out. CCP Ab (IgG) <16 Units <20 Neg Negative. RA confirmed ruled out. ESR 2 mm/h <=15 Normal. Does NOT rule out scleroderma (fibrotic/vascular, not primarily inflammatory) or chronic osteomyelitis (walled off in avascular bone). CRP <3.0 mg/L <8.0 Normal. Same caveat as ESR. MCV Ab IN PROGRESS Pending. 14-3-3 Eta Protein IN PROGRESS Pending. Marker for early joint destruction. DNA (DS) Ab IN PROGRESS Pending. If positive = lupus. SM Ab IN PROGRESS Pending. If positive = lupus. SM/RNP Ab IN PROGRESS Pending. If positive = mixed connective tissue disease. RNP Ab IN PROGRESS Pending. Chromatin (Nucleosomal) Ab IN PROGRESS Pending. If positive = lupus. 7c. Prior Lab Results (Selected) Nov 19, 2025 (Dr. Pico, Quest): CBC normal — WBC 7.3, RBC 5.24, Hgb 15.0, Hct 46.5, Platelets 394 (approaching upper limit). Sep 2025 (Dr. Pico): CMP normal. CRP 1, ESR 2. ANA panel: all negative. Thyroid normal. Autoimmune ruled out (INCORRECTLY — did not test for scleroderma-specific markers or nucleolar ANA pattern). Dec 2025 (Pelham MC ER): Monocytes 10.5% (H), Basophils 1.2% (H), PLT 397, MPV 7.0 L. Patient requested CRP/ESR — refused by ER. Platelet trend: Rising — 394 (Nov) → 397 (Dec). High platelets + low MPV = reactive thrombocytosis consistent with chronic inflammation and/or bone marrow stimulation from hyperparathyroidism (PTH acts directly on marrow within resorbing bone). Nuclear bone scan (Jan 2026, Tc-99m): Active bilateral maxillary uptake. Focal throat uptake. Radiologist read: TMD. Clinical significance: bilateral maxillary pathology + possible parathyroid adenoma. 8. IMAGING HISTORY • Multiple dental X-rays: Various providers, 2025. No specific findings documented by most. • CBCT (Transcend Dental, Jul-Sep 2025): Obtained. VRF #14 missed for 5 months. • CBCT (Feb 2026, self-reviewed): Irregular bone density patterns in anterior maxilla anterior to tooth roots. Heterogeneous marrow pattern bilaterally. Patient interpretation: necrotic/ischemic bone changes. No formal radiology read consistent with clinical findings. • MRI (referenced, ~late 2025): Persistent marrow edema at #3 graft site (9 months post-graft). Mild bilateral marrow edema. Read as unremarkable by radiologist. • Nuclear bone scan (Jan 2026, Mission Imaging): Tc-99m. Active bilateral maxillary uptake. Focal throat uptake. Read as TMD. Clinical significance: active bone metabolism bilaterally + possible parathyroid adenoma at throat. • ENT endoscopy (Nov 2025): Images obtained. Oroantral communication suspected. NEEDED: Post-operative CBCT to evaluate #13, #2, involucrum at #14 site, and extent of remaining disease. Gadolinium-contrast MRI to differentiate living edematous bone from dead avascular bone. 9. WORKING DIAGNOSES 1. Chronic osteomyelitis of maxilla with involucrum formation — Confirmed by intraoperative findings (Nunnally: necrotic marrow, dead vasculature; Palmer: NICO debridement). 18+ months duration. Non-healing despite multiple antibiotic courses (none culture-directed). Bilateral distribution. 2. Normocalcemic primary hyperparathyroidism — PTH 58 with calcium 9.9. PTH failing to suppress at upper limit calcium. Driving osteoclast-mediated bone resorption systemically. MECHANISM 1 of bone destruction: chemical dissolution. 3. Positive ANA, nucleolar pattern (AC-8,9,10) — systemic sclerosis evaluation needed — Associated with scleroderma, which causes small vessel fibrosis and vascular constriction. MECHANISM 2 of bone destruction: ischemic deprivation. Explains bilateral ischemic osteonecrosis, non-healing surgical sites, erythromelalgia, small fiber neuropathy, local anesthesia resistance. 4. Iatrogenic dental injury — 8 composite fillings and RCT redo without documented justification (La Cantera). 100% failure rate. Precipitating event for cascade. 5. Small fiber neuropathy — bilateral feet — Spots with abnormal touch response. Tendon tightening. Erythromelalgia pattern. Consistent with scleroderma vascular involvement. 6. Possible oroantral communication — Sinus involvement bilateral. Addressed partially by Palmer (left side sinus lift, March 5, 2026). Right side status unknown. 7. Gabapentin-calcium-magnesium interaction — Triple interaction at voltage-gated calcium channels in context of hyperparathyroidism. Contributing to symptom burden, sleep disruption, and breakthrough neuropathic pain. 10. OUTSTANDING DIAGNOSTIC NEEDS IMMEDIATE: • DNA Connections PCR pathogen panel: Sample collected March 5, 2026 from extracted tooth #14 root scrapings. First-ever pathogen identification. Will enable culture-directed antibiotic therapy. • Pending antibody results: Anti-dsDNA, SM, SM/RNP, RNP, Chromatin, MCV, 14-3-3 Eta. Will confirm autoimmune subtype. • Post-operative CBCT: Evaluate surgical site, #13 pathology, #2 status, involucrum remnant, extent of remaining disease. • Clindamycin continuation/switch: Only 1 day supply remaining. Cannot lapse with open surgical wound and active bilateral bone infection. SHORT-TERM (1-4 WEEKS): • Endocrinology referral: Sestamibi scan to locate parathyroid adenoma. Determine if surgical parathyroidectomy indicated vs. monitoring. • Rheumatology referral: Scleroderma workup — nailfold capillaroscopy, Scl-70 antibody, anti-centromere antibody, skin assessment, pulmonary function baseline. • Gadolinium-contrast MRI of maxilla: Differentiate living edematous bone (lights up) from dead avascular bone (stays dark). Determines which areas need surgical debridement vs. which may respond to medical management. • Second side surgery (#2, #13 evaluation): With proper anesthesia (IV sedation or general — NOT local infiltration alone given calcium level). Culture tissue intraoperatively. LONG-TERM: • Pentoxifylline/tocopherol/clodronate (PENTOCLO) protocol evaluation: For revascularization of ischemic bone. Requires endocrinology and rheumatology input. • Hyperbaric oxygen therapy evaluation: For non-healing bone in context of vascular compromise. • Bone density scan (DEXA): Baseline assessment given hyperparathyroidism + long-term gabapentin + autoimmune bone involvement. • Gabapentin alternatives: Evaluate non-calcium-channel medications for neuropathic pain given hyperparathyroidism interaction. • Vitamin D dose optimization: Current 10K IU achieving only 37 ng/mL. Target 60-80 ng/mL. May need higher dose or different formulation. 11. PATIENT ADVOCACY NOTE This patient has demonstrated exceptional self-advocacy, diagnostic acumen, and persistence in the face of systematic medical failure. He identified his own calcium trend, ordered his own PTH and ANA panels, collected his own tissue sample for PCR testing, and managed his own complex supplement protocol targeting bone regeneration and vascular support. He has consulted 35+ providers across 4 states over 18 months. He has spent $40,000+ out of pocket. He has lost 4 chewing molars. He has endured 6+ failed antibiotic courses, a failed bone graft, multiple ER visits, and repeated abandonment by providers. He has been misdiagnosed with TMJ, TMD, trigeminal neuralgia, nervous system overload, and phantom pain. His nuclear bone scan showing bilateral active pathology was dismissed. His requests for specific labs were refused. He diagnosed himself. Any provider reviewing this case should understand: this patient knows his body, has done extensive research, and has been correct about his own pathology at every turn. Clinical humility and genuine collaboration are requested.

Multi-Specialist AI Consultation

4 AI specialists debate any clinical case in real-time with adversarial doubt analysis

Coming Soon

MyChart / Epic FHIR Integration

OAuth-based record pull. Connect your MyChart account and auto-import your full medical history, lab results, medications, and visit summaries.

Multi-Provider Record Aggregation

Pull records from multiple health systems into a single unified timeline. One patient, every provider, all in one place.

SMART on FHIR Apps

Launch third-party clinical apps directly within PatientZero using the SMART on FHIR standard. Calculators, decision support, and more.

PDF Consent with E-Signature

Generate signed consent PDFs with embedded digital signatures for your records. Download or share with your provider.

Secure Messaging

End-to-end encrypted messaging between patient and clinician within the shared workspace. HIPAA-compliant communication.

Wearable Data Integration

Import health data from Apple Health, Google Fit, Garmin, and other wearable devices. Correlate vitals with imaging and labs.

Feature availability subject to regulatory review and development timelines.